Key result
Systemic renin-angiotensin system activity was independently associated with indices of hyperinsulinemia in patients with essential hypertension, but not renovascular hypertension.
Observational (n=92)
Systemic renin-angiotensin system activity is independently associated with hyperinsulinemia in patients with essential hypertension, but not in those with renovascular hypertension.
Answers are grounded in this paper and cite their sources.
Should not yet change hypertension management; hypothesis-generating for etiology-specific renin-angiotensin effects on hyperinsulinemia.
Insulin resistance is frequently observed in patients with essential hypertension (EHT), and the renin-angiotensin system (RAS) has been demonstrated to modulate the status of insulin resistance. The aims of present study are to investigate the relationship between systemic RAS and insulin resistance in 82 patients with EHT and compare the impact of RAS to insulin resistance with 10 renovascular hypertension (RVHT) patients who have a highly activated systemic RAS. From patients who were admitted to our hospital, patients with overt diabetes and hypertensives who had secondary HT except RVHT or chronic renal failure were excluded. Plasma renin activity (PRA) was used as an indicator of systemic RAS activity. HOMA-R as an index of insulin resistance and sum of immunoreactive insulin (IRI) during glucose tolerance test (sigmaIRI) and IRI at 120 minutes (IRI120) were used as indices of hyperinsulinemia. In the EHT patients, circulating PRA showed an independent relationship with IRI120 and sigmaIRI after adjusting confounding factors (IRI120: t = 2.70, p = 0.01, sigmaIRI: t = 3.05, p < 0.001). Excluding patients who were taking angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II type 1 receptor blocker (ARBs), the relationship remained in univariate linear regression; after adjustment for confounding factors, PRA showed a tendency to be correlated with sigmaIRI. However, there was no significant relationship between PRA and indices of insulin resistance and hyperinsulinemia in patients with RVHT. In conclusion, the systemic RAS may modulate insulin sensitivity in EHT patients.
No takes yet. Share an insight, caveat, or question.
Matayoshi et al. (2007) conducted an observational in Essential and Renovascular Hypertension (n=92). Systemic renin-angiotensin system activity (Plasma renin activity) was evaluated on Relationship between circulating PRA and indices of hyperinsulinemia (IRI120 and sigmaIRI) (p=<0.001). Systemic renin-angiotensin system activity was independently associated with indices of hyperinsulinemia in patients with essential hypertension, but not renovascular hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: